F16.159

Clinical Causes: Repeated use of hallucinogenic drugs such as LSD, psilocybin, mescaline, or DMT High doses or frequent consumption leading to substance dependence Use in settings that promote risky behaviors or unsafe environments Genetic predisposition or underlying mental health conditions that increase susceptibility Use of hallucinogens combined with other substances like alcohol or stimulants

Key Symptoms: Altered perceptions of reality, including visual or auditory hallucinations Disorganized thinking and speech Agitation or paranoia Episodes of intense fear or anxiety Delusional beliefs unrelated to reality Emotional disturbances, including rapid mood swings Confusion or disorientation Physical symptoms such as increased heart rate, tremors, or dilated pupils

Diagnosis Path: Diagnosis involves a comprehensive clinical assessment by mental health or addiction specialists. The healthcare provider will review the patient's history of substance use, conduct physical and neurological examinations, and may order laboratory tests to rule out other medical causes. In cases of hallucinogen-induced psychotic disorder, the symptoms are usually linked to recent use of hallucinogenic substances. The diagnosis also requires that the psychotic symptoms are not better explained by other psychiatric conditions such as schizophrenia or bipolar disorder, unless directly attributable to substance use. The Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria are also used to confirm the diagnosis.

Treatment Protocols: Management typically involves a combination of approaches tailored to the individual's needs. Treatment options may include: - **Detoxification and medical stabilization** to manage acute symptoms and prevent complications. - **Psychiatric therapy** such as cognitive-behavioral therapy (CBT) to address psychotic symptoms and underlying issues related to substance misuse. - **Medication** may be prescribed to alleviate agitation, psychosis, or other mental health symptoms. - **Support groups and counseling** to promote ongoing recovery and prevent relapse. - **Addressing co-occurring mental health conditions**, including depression, anxiety, or other substance use disorders, to ensure comprehensive care. Long-term follow-up is often necessary to monitor for relapse and to provide ongoing support for mental health and substance use recovery.